Associate Professor Denese C. Marks

Associate Professor Denese C Marks

A/Prof Denese C. Marks

Research Program Leader

Associate Professor, School of Medicine, The University of Sydney

Connect with A/Prof Marks Email LinkedIn Research Gate Pubmed

Denese leads the Product Development team and has over 25 years’ research experience. She holds an adjunct appointment with the School of Medicine, University of Sydney.  Her research focuses on improving blood component processing and storage, including donor attributes that may influence blood component quality, and clinical trials of new blood products.

She has over 100 peer-reviewed publications and holds international  leadership roles with the Biomedical Excellence for Safer Transfusion (BEST) Collaborative, and the International Society of Blood Transfusion.

  • Australian and New Zealand Society of Blood Transfusion (ANZSBT) grant
  • Chief Investigator on two NHMRC-funded clinical trial grants
  • Chief Investigator on an Australian Research Council grant
  • Chief investigator on a Medical Research Future Fund grant
  • Chair of the ISBT Working Party for Blood Components
  • Executive committee of ISBT Cellular Therapies Working Party
  • Vox Sanguinis section editor for Blood Component Collection and Processing
  • Regional Director, The ISBT Board of Regional Directors, Western Pacific Region
  • Team leader of the BEST Collaborative Conventional Components Team
  • Reviewer for journals including Transfusion, Vox Sanguinis, Platelets, Journal of Transfusion and Apheresis Science, and Journal of Proteomics
  • Abstract reviewer for ISBT and AABB conference submissions

Key publications

Risk factors for T-cell lymphopenia in frequent platelet donors: The BEST collaborative study.
Kaufman RM, Marks DC, Flamand Y, Acker JP, Brown BL, Olafson C, Marschner S, Pandey S, Papari M, Petraszko T, Serrano K, Ward D, Bazin R; Biomedical Excellence for Safer Transfusion Collaborative.
X- and gamma-irradiation have similar effects on the in vitro quality of stored red cell components.
Marks DC, Webb RG, Linnane C, Aung HH, Dennington PM, Tan JC
Platelet lysate can support the development of a 3D-engineered skin for clinical application.
Banakh I, Rahman MM, Arellano CL, Marks DC, Mukherjee S, Gargett CE, Cleland H, Akbarzadeh S.
Cell Tissue Res.
A randomized, controlled pilot clinical trial of cryopreserved platelets for perioperative surgical bleeding: the CLIP-I trial (Editorial, p. 2759)
Reade MC, Marks DC, Bellomo R, Deans R, Faulke DJ, Fraser JF, Gattas DJ, Holley AD, Irving DO, Johnson L, Pearse BL, Royse AG, Wong J
Eye drops of human origin-Current status and future needs: Report on the workshop organized by the ISBT Working Party for Cellular Therapies.
Gabriel C, Marks DC, Henschler R, Schallmoser K, Burnouf T, Koh MBC
Vox Sanguinis

* This research was completed prior to starting with Lifeblood